Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Asthma and COPD Drugs Market - Future Scenario, Key Insights, Top Companies 2030 As Revealed In New Report. The market size of global asthma and COPD drugs was $32,988.7 million in 2022, and it is expected to reach $52,049.54 million by 2030.

Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production, and wheezing. COPD is a progressive disease, meaning it typically worsens over time. The main cause of COPD is tobacco smoking, but other factors such as air pollution and genetics can also play a role.

There are various treatment options available for COPD, including medications, pulmonary rehabilitation, and in severe cases, surgery. It is essential for individuals with COPD to work closely with their healthcare providers to manage their symptoms and improve their quality of life.